Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Current Leases of $367000.0 for Q4 2025, up 14.69% year-over-year from $320000.0 in Q4 2024, and up 69.12% quarter-over-quarter from $217000.0 in Q3 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $367000.0 for Q4 2025.
- In Q4 2025, Current Leases rose 14.69% year-over-year to $367000.0; the TTM figure through Dec 2025 stood at $367000.0 (up 14.69% YoY), while the FY2025 annual figure was $367000.0, up 14.69% from the prior year.
- Current Leases for Q4 2025 stood at $367000.0, up from $217000.0 in the prior quarter.
- The five-year high for Current Leases was $3.6 million in Q3 2022, with the low at $211000.0 in Q2 2025.
- The 4-year median for Current Leases is $372000.0 (2024), against an average of $992785.7.
- Peak annual rise in Current Leases reached 19.14% in 2023, while the deepest fall reached 88.59% in 2023.
- Dianthus Therapeutics' Current Leases stood at $350000.0 in 2022, then rose by 19.14% to $417000.0 in 2023, then decreased by 23.26% to $320000.0 in 2024, then grew by 14.69% to $367000.0 in 2025.
- Business Quant data shows DNTH's Current Leases at $367000.0 in Q4 2025, $217000.0 in Q3 2025, and $211000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | 367,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 211,000.00 |
| Mar 31, 2025 | 226,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 417,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.25 Mn |